Drug Name: Aphexda
Active Ingredient: motixafortide
Indications: To use with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma
Approval Date: 9/8/2023
Company: BioLineRx USA Inc
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217159s000lbl.pdf